Found: 14
Select item for more details and to access through your institution.
Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome‐positive acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 9, p. 1680, doi. 10.1002/ajh.27378
- By:
- Publication type:
- Article
High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia‐like fusions.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 6, p. 848, doi. 10.1002/ajh.26908
- By:
- Publication type:
- Article
Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus‐specific T cells in the recipient: A novel strategy to limit antiviral prophylaxis.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 4, p. 588, doi. 10.1002/ajh.26824
- By:
- Publication type:
- Article
Outcome of secondary acute myeloid leukemia treated with hypomethylating agent plus venetoclax (HMA‐Ven) or liposomal daunorubicin‐cytarabine (CPX‐351).
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 6, p. E196, doi. 10.1002/ajh.26157
- By:
- Publication type:
- Article
Outcomes of therapy with venetoclax combined with a hypomethylating agent in favorable‐risk acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 3, p. E59, doi. 10.1002/ajh.26057
- By:
- Publication type:
- Article
Use of monoclonal antibody therapy in hematologic patients with mild-to-moderate COVID-19: A retrospective single-center experience.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 10, p. 11248, doi. 10.1002/cam4.5832
- By:
- Publication type:
- Article
Indications for Allogeneic HCT in Adults with Acute Lymphoblastic Leukemia in First Complete Remission.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Real-World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated With Inotuzumab Ozogamicin.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Late and very late relapsed acute lymphoblastic leukemia: clinical and molecular features, and treatment outcomes.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Decision Analysis of Transplantation for Patients with Myelodysplasia: "Who Should We Transplant Today?".
- Published in:
- Current Hematologic Malignancy Reports, 2020, v. 15, n. 4, p. 305, doi. 10.1007/s11899-020-00573-6
- By:
- Publication type:
- Article
Venetoclax and hypomethylating agents in FLT3‐mutated acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 10, p. 1193, doi. 10.1002/ajh.25929
- By:
- Publication type:
- Article
Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemia.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 3, p. 529, doi. 10.1002/cncr.33967
- By:
- Publication type:
- Article
Sequencing of novel agents in relapsed/refractory B‐cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemia.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 7, p. 1039, doi. 10.1002/cncr.33340
- By:
- Publication type:
- Article
The impact of SARS-CoV2 vaccines on the incidence of graft versus host disease in allogeneic hematopoietic stem cell transplant recipients: a single-center retrospective study.
- Published in:
- Stem Cell Research & Therapy, 2023, v. 14, n. 1, p. 1, doi. 10.1186/s13287-023-03326-3
- By:
- Publication type:
- Article